These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 7906497)
1. Human type I and II IMP dehydrogenases as drug targets. Natsumeda Y; Carr SF Ann N Y Acad Sci; 1993 Nov; 696():88-93. PubMed ID: 7906497 [No Abstract] [Full Text] [Related]
2. Characterization of human type I and type II IMP dehydrogenases. Carr SF; Papp E; Wu JC; Natsumeda Y J Biol Chem; 1993 Dec; 268(36):27286-90. PubMed ID: 7903306 [TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of IMP dehydrogenase in acquired resistance to mycophenolic acid. Snyder FF; Lightfoot T; Hodges SD Adv Exp Med Biol; 1994; 370():725-8. PubMed ID: 7661007 [No Abstract] [Full Text] [Related]
5. Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding. Hager PW; Collart FR; Huberman E; Mitchell BS Biochem Pharmacol; 1995 May; 49(9):1323-9. PubMed ID: 7763314 [TBL] [Abstract][Full Text] [Related]
6. Gene amplification and dual point mutations of mouse IMP dehydrogenase associated with cellular resistance to mycophenolic acid. Lightfoot T; Snyder FF Biochim Biophys Acta; 1994 Mar; 1217(2):156-62. PubMed ID: 7906545 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of a cloned IMP dehydrogenase gene of Candida albicans confers resistance to the specific inhibitor mycophenolic acid. Köhler GA; White TC; Agabian N J Bacteriol; 1997 Apr; 179(7):2331-8. PubMed ID: 9079920 [TBL] [Abstract][Full Text] [Related]
8. Detection of the mycophenolate-inhibited form of IMP dehydrogenase in vivo. McPhillips CC; Hyle JW; Reines D Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12171-6. PubMed ID: 15292516 [TBL] [Abstract][Full Text] [Related]
9. Regulation of an IMP dehydrogenase gene and its overexpression in drug-sensitive transcription elongation mutants of yeast. Shaw RJ; Wilson JL; Smith KT; Reines D J Biol Chem; 2001 Aug; 276(35):32905-16. PubMed ID: 11441018 [TBL] [Abstract][Full Text] [Related]
10. Species-specific inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid. Digits JA; Hedstrom L Biochemistry; 1999 Nov; 38(46):15388-97. PubMed ID: 10563825 [TBL] [Abstract][Full Text] [Related]
11. Probing binding requirements of type I and type II isoforms of inosine monophosphate dehydrogenase with adenine-modified nicotinamide adenine dinucleotide analogues. Chen L; Gao G; Felczak K; Bonnac L; Patterson SE; Wilson D; Bennett EM; Jayaram HN; Hedstrom L; Pankiewicz KW J Med Chem; 2007 Nov; 50(23):5743-51. PubMed ID: 17958343 [TBL] [Abstract][Full Text] [Related]
13. Two distinct cDNAs for human IMP dehydrogenase. Natsumeda Y; Ohno S; Kawasaki H; Konno Y; Weber G; Suzuki K J Biol Chem; 1990 Mar; 265(9):5292-5. PubMed ID: 1969416 [TBL] [Abstract][Full Text] [Related]
14. Novel methylenephosphophosphonate analogues of mycophenolic adenine dinucleotide. Inhibition of inosine monophosphate dehydrogenase. Rejman D; Olesiak M; Chen L; Patterson SE; Wilson D; Jayaram HN; Hedstrom L; Pankiewicz KW J Med Chem; 2006 Aug; 49(16):5018-22. PubMed ID: 16884314 [TBL] [Abstract][Full Text] [Related]
15. Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target. Chong CR; Qian DZ; Pan F; Wei Y; Pili R; Sullivan DJ; Liu JO J Med Chem; 2006 May; 49(9):2677-80. PubMed ID: 16640327 [TBL] [Abstract][Full Text] [Related]
16. Induction of cell differentiation in melanoma cells by inhibitors of IMP dehydrogenase: altered patterns of IMP dehydrogenase expression and activity. Kiguchi K; Collart FR; Henning-Chubb C; Huberman E Cell Growth Differ; 1990 Jun; 1(6):259-70. PubMed ID: 1980599 [TBL] [Abstract][Full Text] [Related]
17. Mutagen-induced resistance to mycophenolic acid in hamster cells can be associated with increased inosine 5'-phosphate dehydrogenase activity. Huberman E; McKeown CK; Friedman J Proc Natl Acad Sci U S A; 1981 May; 78(5):3151-4. PubMed ID: 6114490 [TBL] [Abstract][Full Text] [Related]
18. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate. Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204 [TBL] [Abstract][Full Text] [Related]
19. Is the glucuronide metabolite of MPA pharmacologically active? Nowak I; Wu J; Brayman KL; Shaw LM Transplant Proc; 1997; 29(1-2):337. PubMed ID: 9123028 [No Abstract] [Full Text] [Related]
20. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives. Mitsuhashi S; Takenaka J; Iwamori K; Nakajima N; Ubukata M Bioorg Med Chem; 2010 Nov; 18(22):8106-11. PubMed ID: 20934342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]